Artesunate for the Treatment of Severe Falciparum Malaria
Open Access
- 24 April 2008
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 358 (17) , 1829-1836
- https://doi.org/10.1056/nejmct0709050
Abstract
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented. The article ends with the author's clinical recommendations.Keywords
This publication has 47 references indexed in Scilit:
- Rectal Administration of Artemisinin Derivatives for the Treatment of MalariaJAMA, 2007
- Combination Therapy for Uncomplicated Falciparum Malaria in Ugandan ChildrenJAMA, 2007
- Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparisonThe Lancet, 2007
- Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparisonThe Lancet, 2006
- Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6The Lancet, 2005
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003
- A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Quinine in severe falciparum malaria: evidence of declining efficacy in ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- Intravenous Quinidine for the Treatment of Severe falciparum MalariaNew England Journal of Medicine, 1985
- Quinine and QuinidineJournal of Cardiovascular Pharmacology, 1983